STEVEN C GILMAN Insider Trading
Get free email notifications about insider trading for STEVEN C GILMAN.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of STEVEN C GILMAN. STEVEN C GILMAN is a EVP & Chief Scientific Officer in CUBIST PHARMACEUTICALS INC ($CBST) and a Senior Vice President in CUBIST PHARMACEUTICALS INC ($CBST) and a SVP, Chief Scientific Officer in CUBIST PHARMACEUTICALS INC ($CBST) and a in Vericel Corp ($ASTM) and a Director in Vericel Corp ($ASTM) and a Director in KERYX BIOPHARMACEUTICALS INC ($KERX) and a Director in SCYNEXIS INC ($SCYX) and a Director in MOMENTA PHARMACEUTICALS INC ($MNTA) and a CEO in CONTRAFECT Corp ($CFRX) and a in Akebia Therapeutics, Inc. ($AKBA) and a Director in Akebia Therapeutics, Inc. ($AKBA).
Address: 65 HAYDEN AVENUE LEXINGTON 02421 MA
Companies in which STEVEN C GILMAN is an Insider
Akebia Therapeutics, Inc.
Trading Symbol: AKBAIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of STEVEN C GILMAN:
Holdings: 43,431 shares
Current Value: $429,098
Latest Transaction: Jun 09 2020
$AKBA Market Capitalization: $177.33M
$AKBA Previous Close: $9.88
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
CONTRAFECT Corp
Trading Symbol: CFRXIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of STEVEN C GILMAN: CEO
Holdings: 20,800 shares
Current Value: $35,360
Latest Transaction: Jul 26 2017
$CFRX Market Capitalization: $70.68M
$CFRX Previous Close: $1.70
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
CUBIST PHARMACEUTICALS INC
Trading Symbol: CBSTIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of STEVEN C GILMAN: EVP & Chief Scientific Officer, SVP, Chief Scientific Officer, Senior Vice President
Holdings: 0 shares
Latest Transaction: Jan 21 2015
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
KERYX BIOPHARMACEUTICALS INC
Trading Symbol: KERXIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of STEVEN C GILMAN: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: Dec 13 2018
$KERX Market Capitalization: $574.30M
$KERX Previous Close: $5.35
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
MOMENTA PHARMACEUTICALS INC
Trading Symbol: MNTAIndustry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of STEVEN C GILMAN: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: Oct 01 2020
$MNTA Market Capitalization: $1.29B
$MNTA Previous Close: $18.85
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
SCYNEXIS INC
Trading Symbol: SCYXIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of STEVEN C GILMAN: Director
Holdings: 4,000 shares
Current Value: $12,600
Latest Transaction: Dec 23 2020
$SCYX Market Capitalization: $82.53M
$SCYX Previous Close: $3.15
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Vericel Corp
Trading Symbol: ASTMIndustry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of STEVEN C GILMAN:
Holdings: 3,500 shares
Latest Transaction: Apr 30 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of STEVEN C GILMAN
Sentiment: All, AKBA, CFRX, CBST, KERX, MNTA, SCYX, ASTM
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Apr 30 2021 | ASTM | Vericel Corp | GILMAN STEVEN C | Option Exercise | A | 63.22 | 6,500 | 410,930 | 6,500 | ||
Apr 30 2021 | ASTM | Vericel Corp | GILMAN STEVEN C | Option Exercise | A | 0.00 | 2,600 | 0 | 2,600 | ||
Apr 30 2021 | ASTM | Vericel Corp | GILMAN STEVEN C | Option Exercise | M | 0.00 | 1,750 | 0 | 0 | ||
Apr 30 2021 | ASTM | Vericel Corp | GILMAN STEVEN C | Buy | M | 0.00 | 1,750 | 0 | 3,500 | 1.8 K to 3.5 K (+100.00 %) | |
Dec 23 2020 | SCYX | SCYNEXIS INC | GILMAN STEVEN C | Director | Option Exercise | A | 8.25 | 2,000 | 16,500 | 2,000 | |
Dec 23 2020 | SCYX | SCYNEXIS INC | GILMAN STEVEN C | Director | Option Exercise | A | 7.33 | 2,000 | 14,660 | 2,000 | |
Dec 23 2020 | SCYX | SCYNEXIS INC | GILMAN STEVEN C | Director | Buy | P | 6.25 | 4,000 | 25,000 | 4,000 | 0 to 4 K |